You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 260 No. 20, November 25, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communications
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ribozymes and Their Medical Implications

Thomas R. Cech, PhD

JAMA. 1988;260(20):3030-3034.


Abstract

Certain RNA molecules can mediate their own cleavage or splicing or act as enzymes to promote reactions on substrate RNA molecules. Thus, RNA is not restricted to being a passive carrier of genetic information but can have an active role in directing cellular biochemistry. These findings suggest the possibility that other cellular RNAs, including the RNA components of small nuclear ribonucleoproteins, of the ribosome, and of various ribonucleoprotein enzymes, are catalysts. RNA enzymes (ribozymes) can be used as sequence-specific RNA cleavage agents in vitro, providing useful tools for biochemical studies of RNA. On a more speculative note, ribozymes directed against viral RNAs have the potential of serving as therapeutic agents. Finally, some infectious agents, including hepatitis 8 virus and perhaps poliovirus and rhinoviruses, are themselves ribozymes, providing potential targets for pharmaceuticals.

(JAMA 1988;260:3030-3034)



Author Affiliations

From the Department of Chemistry and Biochemistry, Howard Hughes Medical Institute, University of Colorado, Boulder.


Footnotes

Based on a lecture given at the presentation of the Albert Lasker Basic Medical Research Award, New York, Nov 18,1988.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficient new ribozyme mimics: direct mapping of molecular design principles from small molecules to macromolecular, biomimetic catalysts
Putnam et al.
Nucleic Acids Res 2001;29:2199-2204.
ABSTRACT | FULL TEXT  

Evaluating Group I Intron Catalytic Efficiency in Mammalian Cells
Long and Sullenger
Mol. Cell. Biol. 1999;19:6479-6487.
ABSTRACT | FULL TEXT  

Targeted Reduction of Nucleoside Triphosphate Hydrolase by Antisense RNA Inhibits Toxoplasma gondii Proliferation
Nakaar et al.
J. Biol. Chem. 1999;274:5083-5087.
ABSTRACT | FULL TEXT  

Restoration of Retinoid Sensitivity by MDR1 Ribozymes in Retinoic Acid-Resistant Myeloid Leukemic Cells
Matsushita et al.
Blood 1998;91:2452-2458.
ABSTRACT | FULL TEXT  

Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes
Alvarez-Salas et al.
Proc. Natl. Acad. Sci. USA 1998;95:1189-1194.
ABSTRACT | FULL TEXT  

Circular Ribozymes Generated in Escherichia coli Using Group I Self-splicing Permuted Intron-Exon Sequences
Puttaraju and Been
J. Biol. Chem. 1996;271:26081-26087.
ABSTRACT | FULL TEXT  

Substrate selection rules for the hairpin ribozyme determined by in vitro selection, mutation, and analysis of mismatched substrates.
Joseph et al.
Genes Dev. 1993;7:130-138.
ABSTRACT  

In vitro selection of active hairpin ribozymes by sequential RNA-catalyzed cleavage and ligation reactions.
Berzal-Herranz et al.
Genes Dev. 1992;6:129-134.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.